Adherence, control of cardiometabolic factors and therapeutic inertia in patients with type 2 diabetes in the primary care setting.

Domingo Orozco-BeltránSergio Cinza-SanjurjoJosé Escribano-SerranoFlora López-SimarroGonzalo FernándezAntón Gómez GarcíaKarine Ferreira de CamposMarta Cedenilla Horcajuelo

Published in: Endocrinology, diabetes & metabolism (2021)

Despite a relatively high adherence to all medications for treating diabetes, hypertension and dyslipidemia in patients with T2D in the PC setting in Spain, the control of cardiometabolic risk factors as a whole is far from optimal. This could be related, at least in part, to the high frequency of comorbidity of these patients.

Keyphrases

high frequency
primary care
risk factors
end stage renal disease
transcranial magnetic stimulation
blood pressure
glycemic control
newly diagnosed
type diabetes
chronic kidney disease
ejection fraction
cardiovascular disease
peritoneal dialysis
patient reported outcomes
weight loss
general practice